Stock Taper
Veradermics, founded in 2019 in New Haven, CT, develops novel dermatologic and aesthetic therapeutics, including non-hormonal hair loss treatments and immunotherapy patches for conditions like alopecia, warts, and molluscum contagiosum.

VDPHL01 is a late-stage, non-hormonal oral minoxidil formulation in development for hair loss, aiming to become the first FDA-approved oral treatment for male and female pattern baldness.
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
TVTX | $65.67 | COMPARE |
HELP | $12.18 | COMPARE |
OVID | $2.80 | COMPARE |
ABEO | $5.92 | COMPARE |
PLYX | $2.06 | COMPARE |
XTLB | $2.47 | COMPARE |
LSTA | $1.69 | COMPARE |
ADIL | $5.60 | COMPARE |